Archive | Former employees | Dr. Veselina Uzunova | Projects

Home | CV | Publications | Projects

Participation in scientific projects

  1. H31/16 (2019-present) – Study of the relationship between the phospholipid and the Akt signaling pathway in the pathophysiology in the in vivo model of Alzheimer’s disease. Development of combined therapeutic approaches
  2. H29/12 (2019-present) – Synthesis of new multichromophore chemosensor systems, as logic devices with multi-channel fluorescent output for cell marking and diagnostics in medicine
  3. Post-doc project DCM #577/17.08.2018 (2019-present) New surface-functional magnetic nanoparticles for use in anti-tumortherapy
  4. H21/39 (2018-present) – Complex examination of the physiological basis of the accumulation and the type of secondary metabolites with a high potential for therapeutic use in natural populations of Petasites hybridus (Asteraceae) in Bulgaria. Application of 2D and 3D cell cultures as an adequate in vivo model to assess the antioxidant and anti-tumor potential of plant extracts and preparations
  5. NICTB (2017-present) – National Cellular Technology Infrastructure in Biomedicine part of the National Roadmap for Research The Institute of Biophysics and Biomedical Engineering is a partner in the consortium with a coordinator: Prof. A. Momchilova.
  6. DN 03/1 (2017-present) – Study of oxidative stress in some neurological diseases before and after administration of nanomembrane in therapeutic apheresis.
  7. DFNI-BO 02/5 (2015-2018) – Modulation of metastatic potential of tumor cells by treatment with new alkylphosphocholines and statins in vitro 2D and 3D systems and in in vivo model in hamster.
  8. DFNI BO2/20 (2014-2017) – Introduction in Bulgaria of a nanotechnology membrane (obtained in accelerated proton collider) for separation of polypeptides from human plasma in human diseases.
  9. DFNI BO2/23 (2014-2017) – A new approach to assessing the protective role of antioxidants, produced by photosynthetic plants on cell membranes and microdomains. Application of 3D cell cultures as an adequate model of animal tissues.
  10. DFNP 128/12.05.2016 (2016-2017) – The anti-tumour effect of hemocyanin complexes on the cell sphingolipid signalling pathway and proliferative activity of cancer cells.
  11. Budget subsidy (2015-2017) – Synthesis, structure and cytotoxicity of antimicrobial SiO2-cellulosic hybrid materials with included metal ions.
  12. Budget subsidy (2015-2017) – Conductive, super macroporous hybrid cryogels for regenerative medicine.
  13. DNTS/Germany 01/004 (2014-2016) – Effect of new antineoplastic alkylphosphocholine Erufosine on the PI3K/Akt-MDM2 signalling pathways in cancer cells.
  14. DNTS/Germany 01/003 (2012-2016) – Study the adsorption of plasma proteins and cellular adhesion on conductive 2D- and 3D- dimensional polymer composite surfaces with applications in regenerative medicine.
  15. COST EP4Bio2Med (2012-2016) – European network for development of electroporation – based technologies and treatments – COST ACTION TD1104.

Comments are closed.